Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NeueHealth Inc ( (NEUE) ) has provided an announcement.
On October 2, 2025, NeueHealth Inc. announced the successful closing of its merger with an affiliate of New Enterprise Associates, valuing the company at approximately $1.496 billion. As part of the transaction, NeueHealth’s common stock ceased trading on the NYSE, and the company plans to suspend its SEC reporting obligations. The merger allows NeueHealth to continue its mission of providing consumer-centric care and driving sustainable growth, with its executive leadership team maintaining their roles and equity interests in the newly private company.
The most recent analyst rating on (NEUE) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on NeueHealth Inc stock, see the NEUE Stock Forecast page.
Spark’s Take on NEUE Stock
According to Spark, TipRanks’ AI Analyst, NEUE is a Neutral.
The overall stock score of 49 reflects significant financial challenges, with negative profitability and a weak balance sheet being the most impactful factors. Despite positive sentiment from the earnings call and strategic growth initiatives, the company’s valuation and technical indicators suggest caution.
To see Spark’s full report on NEUE stock, click here.
More about NeueHealth Inc
NeueHealth is a value-driven healthcare company focused on providing high-quality, coordinated care by aligning the interests of health consumers, providers, and payors. The company operates across the ACA Marketplace, Medicare, and Medicaid, delivering clinical care through owned clinics and partnerships with over 3,000 affiliated providers. NeueHealth also supports independent providers and medical groups with technology and services to thrive in performance-based arrangements.
Average Trading Volume: 6,383
Technical Sentiment Signal: Sell
Current Market Cap: $60.94M
See more insights into NEUE stock on TipRanks’ Stock Analysis page.